Available from: www.adipositas-gesellschaft.de Brethauer SA, Kim J, El Chaar M, et al
Some patients may wish to take a "drug holiday" after extended treatment, though the evidence supporting this approach is limited, and the risks of weight regain should be thoroughly discussed
Heres a recap of what weve covered: Orforglipron is a daily oral GLP-1 medication made by Eli Lilly that was approved by the FDA for weight loss and management under the brand name Foundayo in April 2026
Clin Med Insights Endocrinol Diabetes 15:11795514221086634
We cover the wider picture in weight maintenance after stopping GLP-1 medications, and the honest evidence on fiber and weight in general in the best fiber for weight loss
At Bloom Med Spa, we combine expert medical oversight, one-on-one coaching, advanced GLP-1 therapies, high-quality supplements, and a whole-health analysis to create a tailored plan that fits your unique needs